Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Astonishing Deserts All over The Planet You Really want To Visit - 2Find the Insider facts of Viable Advertising: Building a Positive Brand Picture
- 3UN rights chief says Israeli policy in West Bank 'resembles apartheid system'
- 4Unfathomable and Entertaining Legal disputes That Surprise everyone
- 5Instructions to Upgrade the Proficiency of Your Sunlight powered chargers
- The Way to Recuperation: Defeating Dependence
- What really happens when 140 reality stars come face to face with their biggest fans
- Our favorite Space.com stories of 2025
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- Moldova says Russian drones violated airspace
- Becoming amazing at Arranging Pay Raises
- Sought-After Extravagance Ocean side Objections for a Lovely Escape
- Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- James Webb Space Telescope watches our Milky Way galaxy's monster black hole fire out a flare
